[ad_1] SILVER SPRING, Md., July 26, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Palforzia [Peanut (Arachis hypogaea) Allergen […]
CLIMATE CHANGE
Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024
[ad_1] SINGAPORE, July 26, 2024 /PRNewswire/ — Chenghe Acquisition II Co. (the “Company“) today announced that, commencing on July 29, 2024, holders of the units (the “Units“) sold in the Company’s initial public offering may […]
K1 Issues MariaDB Compulsory Acquisition Notices
[ad_1] MANHATTAN BEACH, Calif., July 26, 2024 /PRNewswire/ — Meridian BidCo LLC (“Bidco“), an affiliate of K1 Investment Management, LLC (“K1“), announced earlier this week that its tender offer to acquire the entire issued and […]
Innocan Pharma Submits Investigational New Animal Drug Application to FDA’s Veterinary Center
[ad_1] HERZLIYA, Israel and CALGARY, AB, July 26, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce […]
Anterix to Release First-Quarter Earnings for Fiscal 2025, Hold Analyst and Investor Call
[ad_1] WOODLAND PARK, N.J., July 26, 2024 /PRNewswire/ — Anterix (NASDAQ: ATEX) announced today that it will release its first quarter financial results for the 2025 fiscal year after the close of the market on […]
